Powered by healthtechmovers.com
According to healthtechmovers.com, there are a few trending healthtech stocks that have recently received buy ratings and showing positive investor sentiment, as well as news headlines. With that said, the editors over at healthtechmovers.com, are adding the stocks below to their healthtech stock watchlist. That staff here at financialmarketpress.com, will continue to monitor these healthtech companies to see if the momentum continues. FinancialMarketPress.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more..
Recent BNTX Stock Price: $124.57
Summary: BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.
Eliana Merle analyst at UBS reiterates coverage on BioNTech SE (BNTX) stock in the energy sector with a Hold rating and has set BNTX's stock price target at $ 153.
TipRanks.com reports that BioNTech SE currently has 11 analysts offering 12-month price targets on BNTX and the consensus is a Moderate Buy rating with an average stock price target of $174.20. The most recent BNTX stock price we have is $124.57 and we are not making any BNTX forecasts at this time.
In addition, TradingView issued a Sell rating for BNTX over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Bearish short-term outlook. Remember, securities are volatile, so please do your own research on BNTX. financialmarketpress.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on BNTX, please click here >>
Siemens Healthineers AG, SEMHF
Recent SEMHF Stock Price: $55.95
Summary: N/A
Hassan Al-Wakeel analyst at Barclays reiterates coverage on Siemens Healthineers AG (SEMHF) stock in the energy sector with a Buy rating and has set SEMHF's stock price target at $ 68.72.
TipRanks.com reports that Siemens Healthineers AG currently has 12 analysts offering 12-month price targets on SEMHF and the consensus is a Strong Buy rating with an average stock price target of $64.68. The most recent SEMHF stock price we have is $55.95 and we are not making any SEMHF forecasts at this time.
In addition, TradingView issued a Buy rating for SEMHF over the next month, Barchart.com has a n/a rating and Yahoo! Finance has a Neutral short-term outlook. Remember, securities are volatile, so please do your own research on SEMHF. financialmarketpress.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on SEMHF, please click here >>
Taysha Gene Therapies, TSHA
Recent TSHA Stock Price: $0.80
Summary: Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104 which are in clinical stage. Taysha Gene Therapies Inc. is based in Dallas, Texas.
Kristen Kluska analyst at Cantor Fitzgerald reiterates coverage on Taysha Gene Therapies (TSHA) stock in the energy sector with a Buy rating and has set TSHA's stock price target at $ 2.
TipRanks.com reports that Taysha Gene Therapies currently has 11 analysts offering 12-month price targets on TSHA and the consensus is a Moderate Buy rating with an average stock price target of $5.15. The most recent TSHA stock price we have is $0.80 and we are not making any TSHA forecasts at this time.
In addition, TradingView issued a Sell rating for TSHA over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Neutral short-term outlook. Remember, securities are volatile, so please do your own research on TSHA. financialmarketpress.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on TSHA, please click here >>
Alcon, ALC
Recent ALC Stock Price: $70.54
Summary: Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Cecilia Furlong analyst at Morgan Stanley reiterates coverage on Alcon (ALC) stock in the energy sector with a Hold rating and has set ALC's stock price target at $ 78.
TipRanks.com reports that Alcon currently has 13 analysts offering 12-month price targets on ALC and the consensus is a Moderate Buy rating with an average stock price target of $82.40. The most recent ALC stock price we have is $70.54 and we are not making any ALC forecasts at this time.
In addition, TradingView issued a Buy rating for ALC over the next month, Barchart.com has a Weak buy rating and Yahoo! Finance has a Neutral short-term outlook. Remember, securities are volatile, so please do your own research on ALC. financialmarketpress.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on ALC, please click here >>
The editors at financialmarketpress.com use a variety of research tools to generate our watchlists and research reports. One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. TipRanks.com tracks and measures the performance of over 50,000 financial experts. The TipRanks Star RankingTM is calculated based on expert success rate, average return and statistical significance. Get more from TipRanks.com here >>
FinancialMarketPress.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinancialMarketPress.com.
==============================================================================
